From a email sent to colleagues, I know nothing more about this than what’s below… Jo
Via the Barts Health NHS Trust
Diabetes Review, Engagement and Management via Skype
Are web-based consultations a useful tool for supporting patient self-management in diabetes?
18 March 2015
West Ham United Football Club, Boleyn Ground
Green Street, Upton Park, London E13 9AZ
Focus & Aims
The DREAMS study, led by Barts Health NHS Trust, explored the role of remote (‘Skype’) consultations in patients who find it difficult to engage with and attend diabetes services. The research, which ran between January 2012 and December 2014, aimed to provide a better understanding of how the introduction of remote consultations alter patterns of service use, the experience of remote consultations from the perspective of patients and service staff, and the challenges of introducing remote consultations in a clinical setting.
The purpose of the workshop is to share and discuss key findings from the DREAMS study. The event will focus on the personal experience of patients and service staff using Skype consultations, quantitative and qualitative outcomes that informed its implementation, and the key lessons and recommendations for other services.
The workshop is organised by the research team involved in the DREAMS study, which was funded by the Health Foundation.
Presentations will be by clinical and research staff, and patients involved in the DREAMS study. Lunch will be provided after presentation and discussion sessions
Presentation topics will include:
- Background and aims of the DREAMS study
- How the introduction of Skype altered service use
- Patient and service staff views and experience of Skype consultations
- Guidance and recommendations on implementation and use of Skype in clinic settings
The event is free but places are limited, so to book a place email Joe Wherton at firstname.lastname@example.org , before March 6th. For more information about the event please contact Joe Wherton on 020 7882 2512 or Desiree Campbell-Richards on 020 7363 8569.
“ISO 15197:2013: In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus”
The new (I say new, they came out last year but I’ve been out of the ‘diabetosphere’ for a while) guidelines can be found here but they cost CHF 154,000 which is a wee bit more than I want to cough up to read them. You can preview some of the document here.
The ISO’s own blog has written about this “More accurate self-testing results for diabetes patients with new ISO standard“.
“The reliability of self-monitored glucose values is a prerequisite for an efficient and safe approach to treat patients to their target. Accuracy of SMBG, therefore, is a key aspect in this regard.9 Recently, accuracy requirements have been tightened. According to the revised ISO standard 15197:2013, 95% of the blood glucose (BG) results shall fall within ±15 mg/dl of the reference method at BG concentrations < 100 mg/dl and within ±15% at BG concentrations ≥ 100 mg/dl.10 The less restrictive ISO standard 15197:2003 loses its validity after a transitional period of 3 years.11”
Source: Schnell and Erbach (2014) Impact of a Reduced Error Range of SMBG in Insulin-treated Patients in GermanyJournal of Diabetes Science and Technology February 5, 2014, doi: 10.1177/1932296813516206
There’s also been some discussion on the children-with-diabetes forum: Accuracy of blood glucose meters draws scrutiny childrenwithdiabetes (21 May 2013).
See also FDA to ISO 15197: Not good enough The Westgard Rules blog (15 January 2014)
“FDA believes that the criteria set forth in the ISO 15197 standard do not adequately protect patients using BGMS devices in professional settings, and does not recommend using these criteria for BGMS devices.” – quote excerpted from recent FDA draft guideline on blood glucose meters (line 277).
This is a sort of but not quite press release about a new diabetes app for people with smartphones. Not investigated it myself, this comes from the wonderful CHAIN (Contact, Help, Advice & Information Network) which I have recommended many times on this blog before and continue to do so. It’s free to sign up.
‘I would like to let people with an interest in Diabetes know about a brand new free application Patient.co.uk have launched ahead of next week’s Diabetes Week, which helps people with either type 1 or type 2 diabetes to easily record and monitor their condition.
Called ‘Diabetes Manager’ the application tracks various key indicators such as the number and severity of hypos, blood glucose levels and food and drink intake and is completely customisable.
Commenting on the application, Dr Hayley Willacy, who peer-reviewed Diabetes Manager said: “One of the most useful and practical aspects to this app is the ability for patients to see their records easily in a graph and save their most notable records as talking points to discuss with their GP. What’s more they can export and share their results with their doctor.”
David Cragg, a patient with diabetes who provided user insight to our team during the development of the app said: “It’s great that an organisation such as Patient.co.uk has engaged people with diabetes to help shape their iPhone application. The resulting application has some truly unique features, such as marking notable entries to help locate results when discussing concerns with health care professionals.”
To find out more and download the app you can visit: http://www.patient.co.uk/press-releases/launch-of-free-clinically-backed-diabetes-manager-app ‘
See also: Diabetes UK Tracker app for people with diabetes (available for iPhone and Android) – this app won the Third Sector Excellence Award for use of digital media, in September 2012.